{"transactions":[{"id":4623697,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-09-18","kind":"sale","planned":false,"acquired":false,"shares":9132,"price":3.2364,"value":29554.8048,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.15 to $3.41. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":25384,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":4623696,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-09-17","kind":"sale","planned":false,"acquired":false,"shares":6545,"price":3.3183,"value":21718.2735,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.22 to $3.67. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":34516,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":4623695,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1889,"price":3.774,"value":7129.086,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units granted on October 22, 2025. The shares were sold at prices ranging from $3.60 to $4.14. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the \"SEC\"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41061,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":4623694,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-09-21T22:03:56.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":637,"price":3.876,"value":2469.012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":2950,"source":{"system":"sec-edgar","filing":"0001193125-26-396890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526396890/ownership.xml","form_type":"4"}},{"id":919447,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-04T16:32:38.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026."}],"balance_after":20000,"derivative":{"exercise_price":6.71,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-037697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526037697/ownership.xml","form_type":"4"}},{"id":919446,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2026-02-04T16:32:38.000Z","date":"2025-12-05","kind":"purchase","planned":false,"acquired":true,"shares":125,"price":4.607,"value":575.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":2313,"source":{"system":"sec-edgar","filing":"0001193125-26-037697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312526037697/ownership.xml","form_type":"4"}},{"id":967630,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":0,"derivative":{"exercise_price":7.02,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":34999},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967629,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":34999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":34999,"derivative":{"exercise_price":5.44,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":34999},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967628,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":0,"derivative":{"exercise_price":14.602,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":21999},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967627,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":21999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":21999,"derivative":{"exercise_price":5.44,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":21999},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967626,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":0,"derivative":{"exercise_price":25.4,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":11749},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967625,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":11749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":11749,"derivative":{"exercise_price":5.44,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":11749},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967624,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on February 27, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2033-02-26","underlying":"Common Stock","underlying_shares":12499},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967623,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":12499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reporting person agreed to cancellation of an option granted on February 27, 2023, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":12499,"derivative":{"exercise_price":5.44,"expiration_date":"2033-02-26","underlying":"Common Stock","underlying_shares":12499},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967622,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":61.6,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":10499},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967621,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":10499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":10499,"derivative":{"exercise_price":5.44,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":10499},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967620,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":400,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967619,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":5000,"derivative":{"exercise_price":5.44,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967618,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3927,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":86.8,"expiration_date":"2030-09-02","underlying":"Common Stock","underlying_shares":3927},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967617,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":3927,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":3927,"derivative":{"exercise_price":5.44,"expiration_date":"2030-09-02","underlying":"Common Stock","underlying_shares":3927},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967616,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7614,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on July 29, 2020, in exchange for a new option having a lower price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":56,"expiration_date":"2030-07-28","underlying":"Common Stock","underlying_shares":7614},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":967615,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-16T17:11:13.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":7614,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reporting person agreed to cancellation of an option granted on July 29, 2020, in exchange for a new option having a lower price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":7614,"derivative":{"exercise_price":5.44,"expiration_date":"2030-07-28","underlying":"Common Stock","underlying_shares":7614},"source":{"system":"sec-edgar","filing":"0001193125-25-321146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525321146/ownership.xml","form_type":"4"}},{"id":1013836,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2025-10-24T19:18:29.000Z","date":"2025-10-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F3","text":"The restricted stock units subject to the award will vest in full on September 15, 2026, assuming continued employment through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares represent restricted stock units that were received as an award, for no consideration. Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":42188,"source":{"system":"sec-edgar","filing":"0001193125-25-250332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525250332/ownership.xml","form_type":"4"}},{"id":1013835,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2025-10-24T19:18:29.000Z","date":"2025-06-06","kind":"purchase","planned":false,"acquired":true,"shares":125,"price":5.492,"value":686.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan and therefore exempt under Rule 16b-3(c)"}],"balance_after":2188,"source":{"system":"sec-edgar","filing":"0001193125-25-250332","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000119312525250332/ownership.xml","form_type":"4"}},{"id":1159323,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-05T20:35:34.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025."}],"balance_after":700000,"derivative":{"exercise_price":0.351,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0000950170-25-063840","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000095017025063840/ownership.xml","form_type":"4"}},{"id":1159322,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2025-05-05T20:35:34.000Z","date":"2024-06-06","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.6374,"value":1593.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"and therefore exempt under Rule 16b-3(c)"},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":38772,"source":{"system":"sec-edgar","filing":"0000950170-25-063840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000095017025063840/ownership.xml","form_type":"4"}},{"id":1159321,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Common Stock","published_at":"2025-05-05T20:35:34.000Z","date":"2024-12-16","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.4965,"value":1241.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"and therefore exempt under Rule 16b-3(c)"},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":41272,"source":{"system":"sec-edgar","filing":"0000950170-25-063840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000095017025063840/ownership.xml","form_type":"4"}},{"id":1449376,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-24T17:23:18.000Z","date":"2024-07-23","kind":"grant","planned":false,"acquired":true,"shares":440000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024."}],"balance_after":440000,"derivative":{"exercise_price":0.7301,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":440000},"source":{"system":"sec-edgar","filing":"0000950170-24-086146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000095017024086146/ownership.xml","form_type":"4"}},{"id":1591769,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T13:27:52.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":235000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024."}],"balance_after":235000,"derivative":{"exercise_price":1.27,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":235000},"source":{"system":"sec-edgar","filing":"0000950170-24-026996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000095017024026996/ownership.xml","form_type":"4"}},{"id":1712636,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T13:40:19.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":0.95,"value":7125.0,"ownership":{"direct":true},"balance_after":36272,"source":{"system":"sec-edgar","filing":"0001209191-23-058458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919123058458/doc4.xml","form_type":"4"}},{"id":1712635,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T13:40:19.000Z","date":"2023-12-06","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.782,"value":1955.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":28772,"source":{"system":"sec-edgar","filing":"0001209191-23-058458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919123058458/doc4.xml","form_type":"4"}},{"id":1712634,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T13:40:19.000Z","date":"2023-06-06","kind":"purchase","planned":false,"acquired":true,"shares":1829,"price":1.1815,"value":2160.9635,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":26272,"source":{"system":"sec-edgar","filing":"0001209191-23-058458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919123058458/doc4.xml","form_type":"4"}},{"id":1987181,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-28T16:28:04.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023."}],"balance_after":250000,"derivative":{"exercise_price":1.59,"expiration_date":"2033-02-26","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-013666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919123013666/doc4.xml","form_type":"4"}},{"id":2028555,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-07T16:50:03.000Z","date":"2022-12-06","kind":"purchase","acquired":true,"shares":1789,"price":1.1815,"value":2113.7035,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":24443,"source":{"system":"sec-edgar","filing":"0001209191-23-007567","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919123007567/doc5.xml","form_type":"5"}},{"id":2028554,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-07T16:50:03.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":2500,"price":1.6405,"value":4101.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":22654,"source":{"system":"sec-edgar","filing":"0001209191-23-007567","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919123007567/doc5.xml","form_type":"5"}},{"id":2378723,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-23T21:21:19.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022."}],"balance_after":210000,"derivative":{"exercise_price":3.08,"expiration_date":"2032-02-17","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0000899243-22-007524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000089924322007524/doc4.xml","form_type":"4"}},{"id":2478986,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-09T16:05:23.000Z","date":"2021-12-08","kind":"purchase","acquired":true,"shares":5000,"price":4.715,"value":23575.0,"ownership":{"direct":true},"balance_after":20154,"source":{"system":"sec-edgar","filing":"0000899243-21-047518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000089924321047518/doc4.xml","form_type":"4"}},{"id":2478985,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-09T16:05:23.000Z","date":"2021-12-06","kind":"purchase","acquired":true,"shares":35,"price":4.64,"value":162.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":15154,"source":{"system":"sec-edgar","filing":"0000899243-21-047518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000089924321047518/doc4.xml","form_type":"4"}},{"id":2478984,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-09T16:05:23.000Z","date":"2021-06-04","kind":"purchase","acquired":true,"shares":1221,"price":16.65,"value":20329.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the issuer's Employee Stock Purchase Plan."}],"balance_after":15119,"source":{"system":"sec-edgar","filing":"0000899243-21-047518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000089924321047518/doc4.xml","form_type":"4"}},{"id":2872052,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-09T15:23:29.000Z","date":"2021-02-09","kind":"purchase","acquired":true,"shares":1200,"price":20,"value":24000.0,"ownership":{"direct":true},"balance_after":13898,"source":{"system":"sec-edgar","filing":"0001209191-21-008741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919121008741/doc4.xml","form_type":"4"}},{"id":2874582,"issuer":{"id":8082,"kind":"organization","name":"Bolt Biotherapeutics, Inc.","symbol":"BOLT"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T17:02:01.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/48th of the Shares will vest upon the Reporting Person completing each month of continuous service following February 4, 2021."}],"balance_after":100000,"derivative":{"exercise_price":20,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-008521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724190/000120919121008521/doc4.xml","form_type":"4"}},{"id":3187184,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-02T15:30:39.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of shares granted shall vest monthly over the next thirty-six (36) months."}],"balance_after":360000,"derivative":{"exercise_price":0.4149,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0000899243-20-009976","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924320009976/doc4.xml","form_type":"4"}},{"id":3187183,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-02T15:30:39.000Z","date":"2019-11-29","kind":"purchase","acquired":true,"shares":6000,"price":0.3655,"value":2193.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the Issuer's stock purchase plan."}],"balance_after":127697,"source":{"system":"sec-edgar","filing":"0000899243-20-009976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924320009976/doc4.xml","form_type":"4"}},{"id":3187182,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-04-02T15:30:39.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":6000,"price":0.6461,"value":3876.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired under the Issuer's stock purchase plan."}],"balance_after":121697,"source":{"system":"sec-edgar","filing":"0000899243-20-009976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924320009976/doc4.xml","form_type":"4"}},{"id":3572679,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-01T16:14:59.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 29, 2019. Thereafter, one forty-eighth (1/48th) of shares granted shall vest monthly over the next thirty-six (36) months."}],"balance_after":75000,"derivative":{"exercise_price":1.215,"expiration_date":"2029-03-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-19-009382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924319009382/doc4.xml","form_type":"4"}},{"id":3620063,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-04T15:08:29.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":63697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an incentive bonus paid to the reporting person pursuant to the Issuer's 2018 Bonus Plan. In accordance with the terms of the 2018 Bonus Plan, the reporting person received 50% of his bonus payment in a number of shares of the Issuer's common stock calculated as set forth in the 2018 Bonus Plan."}],"balance_after":115697,"source":{"system":"sec-edgar","filing":"0000899243-19-005709","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000089924319005709/doc4.xml","form_type":"4"}},{"id":3709993,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO,Sr.V.P. Finance, Corp.Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-03T19:16:35.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five per cent (25%) of each option shall vest on the first anniversary of the vesting commencement date and one forty-eighth (1/48th) of each option shall vest over the following thirty-six (36) months thereafter."}],"balance_after":150000,"derivative":{"exercise_price":0.4157,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001179110-19-000328","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000117911019000328/edgar.xml","form_type":"4"}},{"id":3734568,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO,Sr.V.P. Finance, Corp.Dev."}}],"security":"Common Stock","published_at":"2018-12-12T16:57:44.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":40000,"price":0.47,"value":18800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 6,000 shares acquired under the Issuer's stock purchase plan on May 31, 2018 and  6,000 shares acquired under the Issuer's stock purchase plan on November 30, 2018."}],"balance_after":52000,"source":{"system":"sec-edgar","filing":"0001179110-18-013757","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000117911018013757/edgar.xml","form_type":"4"}},{"id":4144732,"issuer":{"id":85616,"kind":"organization","name":"Viracta Therapeutics, Inc.","symbol":"VIRX"},"owners":[{"id":67750,"kind":"person","name":"Quinn William P.","position":1,"cik":"0001724190","reported_name":"Quinn William P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO,Sr.V.P. Finance, Corp.Dev."}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-04T18:00:17.000Z","date":"2017-11-30","kind":"grant","acquired":true,"shares":232500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-Five (25%) of the shares subject to the option will vest on November 30, 2018, the first anniversary of the effective date, and the remaining shares vest in thirty-six (36) equal monthly installments thereafter, until either the option is fully vested or Mr. Quinn's employment ends, whichever occurs first."}],"balance_after":232500,"derivative":{"exercise_price":2.89,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":232500},"source":{"system":"sec-edgar","filing":"0001179110-17-014854","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061027/000117911017014854/edgar.xml","form_type":"4"}}]}